Bicycle Therapeutics is a biopharmaceutical company specializing in the development of novel therapeutics based on its proprietary Bicycle peptide platform. This platform allows for the design of bicyclic peptides that are engineered for targeted therapeutic applications, particularly in oncology and other serious diseases. Bicycle Therapeutics aims to revolutionize the treatment landscape by creating precision medicines that improve patient outcomes. Committed to scientific excellence and innovation, the company values collaboration across multidisciplinary teams to advance drug discovery and development. Bicycle Therapeutics fosters an inclusive workplace culture, recognizing that a diverse workforce drives creativity and enhances problem-solving capabilities, ultimately contributing to its mission of delivering transformative therapies.